Cronos Group Inc CRON.TO reported quarterly adjusted earnings of 2 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported breakeven earnings per share. The mean expectation of three analysts for the quarter was for a loss of one cent per share. Wall Street expected results to range from -2 cents tozero cents per share.
Revenue rose 38.1% to $34.26 million from a year ago; analysts expected $29.10 million.
Cronos Group Inc's reported EPS for the quarter was 2 cents.
The company reported quarterly net income of $8.35 million.
Cronos Group Inc shares had fallen by 10.0% this quarter and lost 5.7% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 100% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and 1 "sell" or "strong sell."
The average consensus recommendation for the pharmaceuticals peer group is also "hold"
Wall Street's median 12-month price target for Cronos Group Inc is 2.79
This summary was machine generated from LSEG data November 12 at 03:28 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Sep. 30 2024 | -0.01 | 0.02 | Beat |
Jun. 30 2024 | 0.00 | -0.02 | Missed |
Mar. 31 2024 | -0.01 | -0.01 | Met |
Dec. 31 2023 | -0.01 | -0.05 | Missed |
Comments